Link
Pfizer-BioNTech COVID-19 vaccine: Health Canada recommendations for people with serious allergies
Organization: Health CanadaPublished: 2020
"Health Canada has conducted a rigorous scientific review of the available scientific evidence to assess the safety, efficacy and quality of the Pfizer-BioNTech COVID-19 vaccine. No major safety concerns have been identified. Based on the current information, Health Canada has assessed that this vaccine’s benefits outweigh its risks." - Pfizer-BioNTech COVID-19 vaccine: Health Canada recommendations for people with serious allergies
Resource Group:
Implementation Tool
Product Type: Guide
Program Delivery and Evaluation
Clinics
Vaccine Management
Storage and Handling
Allocation and Distribution
Vaccine Safety and Development
Vaccine Safety
Sub Topics: Vaccine Safety and Development
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Product Type: Guide
Category:
Program Planning and Delivery,Program Delivery and Evaluation,Clinics,Vaccine Management,Storage and Handling,Allocation and Distribution,Vaccine Safety and Development,Vaccine Safety,Sub Topics: Vaccine Safety and Development,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Program Planning and DeliveryProgram Delivery and Evaluation
Clinics
Vaccine Management
Storage and Handling
Allocation and Distribution
Vaccine Safety and Development
Vaccine Safety
Sub Topics: Vaccine Safety and Development
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Audience:
Health Care Professional
Population: Seniors
High Risk Adults
Healthcare Personnel
Indigenous Populations
Region: National
Population: Seniors
High Risk Adults
Healthcare Personnel
Indigenous Populations
Region: National
Language:
English
AudioResource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.